UNC antibody treatment could reduce COVID-19 hospitalizations by nearly 80%

Researchers with the University of North Carolina at Chapel Hill are looking into a new treatment for COVID-19. Vice chair of the study, Dr. David Wohl, said this monoclonal antibody cocktail is able to attach to the virus and prevent it from hurting people.